SCHEMBL19081763

SCHEMBL19081763

c1ccc(-c2c3ccccc3c(-c3ccc4oc5ccc6sc7c8ccccc8ccc7c6c5c4c3)c3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 6/20 0.40
CYP1B1 Q16678 5/20 0.40
CYP1A2 P05177 5/20 0.38
ABCG2 Q9UNQ0 5/20 0.38
PAX8 Q06710 2/20 0.38
FYN P06241 1/20 0.38
MAPK3 P27361 1/20 0.38
AHR P35869 1/20 0.38
KDM4E B2RXH2 4/20 0.34
HPGD P15428 4/20 0.34
MAPT P10636 3/20 0.34
TSHR P16473 3/20 0.34
HSD17B10 Q99714 3/20 0.34
TDP1 Q9NUW8 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
GLA P06280 2/20 0.34
HTT P42858 1/20 0.34
MAPK1 P28482 2/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081892 0.96 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL24518919 0.93 KDM4E (0.35) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19081995 0.92 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19081764 0.91 ABCG2 (0.40) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19081792 0.90 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2PAX8AHR
SCHEMBL19082019 0.90 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19076866 0.89 PLA2G2A (0.38) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19081761 0.88 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19081879 0.87 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19081819 0.87 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2ABCG2PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.